Creation of the Biobank Related to Eye Disease

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01240343

Acronym

BioBank

Enrollment

669

Registered

2010-11-15

Start date

2009-06-30

Completion date

2017-12-04

Last updated

2018-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye Diseases

Keywords

Biobank, Genetics

Brief summary

The purpose of this study is to develop a BioBank (a specialized lab) and collect blood, fluids and/or other tissue samples to study eye diseases.

Detailed description

The purpose of the Biobank related to eye disease at Beaumont Hospital is to help connect specialties and Specialists with each other, outside traditional limits of hospital or laboratory departments. The specimens (blood, fluids, and/or tissue samples) that will be collected from men, women and children will assist the researchers in a variety of studies on human eye diseases. Research utilizing these specimens will allow for an increased understanding of the etiology, disease process, and response to treatments for various eye diseases, and will provide opportunities to subsequently improve our management decisions. Furthermore, projects that cross over between subspecialties are sparse and that is a limiting factor for the development of research that takes a more comprehensive approach.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

All pediatric and adult patients age 0-99 years -

Exclusion criteria

All patients who do not agree to consent for collection of blood, fluids, tissue. Patients who are cognitively impaired and are not able to verbalize understanding of the risks/benefits. \-

Design outcomes

Primary

Measure	Time frame	Description
To build the platform for a novel application of translational research that links cutting edge molecular laboratory techniques to clinical outcome studies	—	Biobanks can be used for numberous discovery applications such as: identification and structural characterization of human genes, expression analysis, or discovery proteomics. Biological specimens, when coupled with standardized treatment and outcome data, will be essential resources for the identification, characterization and validation of biomarkers that are predictive of disease and treatment.

Countries

United States

Outcome results